ALHYG — Hybrigenics SA Share Price
Last trade - 00:00- €3.06m
- €2.60m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.32 | ||
| Price to Tang. Book | 0.32 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -4.65% | ||
| Return on Equity | -0.96% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | n/a | 0.08 | 0.23 | -0 | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hybrigenics SA is France-based Company engaged in the biotechnological sector. It specializes in the research and development of drugs intended for cancer treatment and supplies scientific services in the protein interaction field. The Company is specialized in the research and development (R&D) of drugs to fight cancer. It is organized in two units: Hybrigenics Pharma for internal R&D, which develops a research program aimed at such diseases as melanoma and prostate cancer; and Hybrigenics Services for commercial business, mainly engaged in protein interaction information and solutions. Hybrigenics SA’s main development program is based on inecalcitol, a vitamin D analogue, for prostate cancer treatment. It operates through Hybrigenics Corporation and Imaxio.
Directors
- Last Annual
- December 31st, 2021
- Last Interim
- December 31st, 2021
- Incorporated
- January 1st, 1998
- Public Since
- December 17th, 2007
- No. of Employees
- 17
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 261,249,246
- Address
- 3-5 impasse Reille, PARIS, 75014
- Web
- https://www.hybrigenics.com/
- Phone
- +33 158103800
- Auditors
- Deloitte
Upcoming Events for ALHYG
Similar to ALHYG
Affluent Medical SAS
Euronext - Paris
Alpha MOS SA
Euronext - Paris
Amplitude Surgical SA
Euronext - Paris
Biomerieux SA
Euronext - Paris
Biosynex SA
Euronext - Paris
FAQ
As of Today at 19:10 UTC, shares in Hybrigenics SA are trading at €0.01. This share price information is delayed by 15 minutes.
Shares in Hybrigenics SA last closed at €0.01 and the price had moved by -81.1% over the past 365 days. In terms of relative price strength the Hybrigenics SA share price has underperformed the FTSE Global All Cap Index by -82.57% over the past year.
The overall consensus recommendation for Hybrigenics SA is Strong Sell. You can view the full broker recommendation list by unlocking its StockReport.
Hybrigenics SA does not currently pay a dividend.
Hybrigenics SA does not currently pay a dividend.
Hybrigenics SA does not currently pay a dividend.
To buy shares in Hybrigenics SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €0.01, shares in Hybrigenics SA had a market capitalisation of €3.06m.
Here are the trading details for Hybrigenics SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALHYG
Based on an overall assessment of its quality, value and momentum Hybrigenics SA is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hybrigenics SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -80.5%.
As of the last closing price of €0.01, shares in Hybrigenics SA were trading -64.94% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Hybrigenics SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Hybrigenics SA's management team is headed by:
- Jean-Paul Ansel - CHM
- Julien Gauthier - CEO
- See-Nuan Simonyi - DRC
- Philippe Nerin - IND